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Health Policy Statement on Public Reporting May 20, 2008:1993–2001reamble
his document is an official American College of Cardiol-
gy Foundation (ACCF) health policy statement. This
ategory of documents is intended to promote or advocate a
osition or is informational in nature and may offer guid-
nce to the stakeholder community regarding the ACCF’s
tance on health care policies and programs. Health policy
tatements are not intended to offer clinical guidance and do
ot contradict existing ACCF clinical policy. These docu-
ents fall under the purview of the ACCF Quality Strategic
irections Committee (QSDC). The ACCF QSDC is re-
ponsible for developing and implementing all policies and
rocedures related to topic selection, commissioning writing
ommittees, and defining document methodologies.
The presidential Task Force on Performance Assessment,
ecognition, Reinforcement, and Reward (PAR3) brings
ogether various areas of the College such as the Advocacy
ommittee, the National Cardiovascular Data Registry, the
erformance Measurement Task Force, the Informatics
ommittee, the Education Committee, the QSDC, and the
oalition of Cardiovascular Organizations to formulate
CCF position and strategy in the value-based purchasing
nvironment. The PAR3 Task Force recommended the
evelopment of this health policy statement to document
he official position of the ACCF regarding public reporting
f physician performance data. As payer and purchasers
ove to implement value-based health care purchasing
rograms (commonly known as pay-for-performance [P4P]
rograms), medical specialty societies must weigh in on the
esign and implementation of program elements in an effort
o influence stakeholder perspectives and provide meaning-
ul guidance to members.
The Writing Committee made every effort to avoid any
ctual, potential, or perceived conflict of interest that might
rise as a result of industry relationships or personal interest.
pecifically, all members of the writing committee, as well
s peer reviewers of the document, were asked to provide
isclosure statements of all such relationships. Please see
ppendix 1 for a listing of the author relationships with
ndustry. Relationships with industry of peer reviewers are
isted in Appendix 2.
John E. Brush, Jr, MD, FACC, Chair
ACCF Quality Strategic Directions Committee (QSDC)
ntroduction
he U.S. health care system and its shortcomings are
ttracting the scrutiny of all those it touches: patients, their
aregivers, providers, payers, employers, and policy-makers.
espite the extraordinary resources expended, unacceptable
aps in care and quality persist. In an effort to close those
aps, public reporting of physician, health plan, and insti-
utional performance is increasingly being utilized, as evi- benced by the 211 entries in the Report Card Compendium,
database maintained by the Agency for Healthcare Re-
earch and Quality (AHRQ) (1). These assessments vary by
arget, methodology, level of transparency, motive, and
otential consequences.
Employers, who are among the major purchasers of
ealth care, are now investing in public reporting as a means
o accelerate quality improvement and steer employees to
he “best” performers. Hospitals are participating in perfor-
ance reporting through public-private collaborations, such
s the Hospital Quality Alliance (HQA) and the Centers
or Medicare and Medicaid Services (CMS) Premier Hos-
ital Quality Incentive Demonstration (HQID), the latter
dding bonus payments to the reporting equation. Health
lans are publishing performance reports on individual
hysicians in an effort to influence their members’ decision-
aking. Health care providers and professional organiza-
ions are just beginning to provide information regarding
uality of care in an understandable and readily accessible
ay. Finally, “boomer” generation patients, as activated
onsumers of health care services, are predicted to expect
nd, in fact, demand ready access to comparative informa-
ion to guide their health care choices.
The ACCF is supportive of accountability in health care
ut has concerns regarding public disclosure of performance
etrics at the individual physician level. Prior statements by
he ACCF have discussed important issues as they relate to
erformance profiling, such as the principles to guide
election of performance measures (2), risk adjustment
ethodologies (3), and the policies for pay for performance
4). This health policy statement will center on “physician-
evel” performance reporting. We review the history of
ublic reporting of physician-specific performance metrics,
ropose principles to guide public reporting on the quality
f health care provided by cardiovascular specialists, and
ummarize what the ACCF is doing to assist physicians to
mprove their own quality of care. We point out the
CCF’s concerns about public reporting and, through the
roposed principles, suggest a way of addressing those
oncerns and of achieving enhanced transparency that is
eaningful to payers, providers, and patients.
istory and Current Status
f Public Reporting
ardiovascular specialists, specifically cardiac surgeons, have
een the object of public reporting for over two decades in
oth federal and state initiatives. These efforts initially were
irected at hospital performance assessment, with physician
ata only indirectly included in conjunction with the hos-
ital processes being measured. The Health Care Financing
dministration (HCFA)—now CMS—took the lead in
his area with the release of hospital-specific coronary artery
ypass grafting (CABG) mortality data in 1987 (5). This
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May 20, 2008:1993–2001 Health Policy Statement on Public Reportingffort was later withdrawn because of objections relative to
he methodoloy employed (6). It, nevertheless, spawned
everal physician-led quality improvement initiatives, in-
luding the Northern New England Cardiovascular Study
roup (NNECSG) and the Society of Thoracic Surgeon’s
STS) National Cardiac Surgery Database, which have
roven to be highly successful mechanisms for stimulating
uality improvement (7,8).
States including New York (9), Pennsylvania (10), and
assachusetts (11) have also implemented cardiovascular
ublic reporting programs. The New York Cardiac Surgery
eporting System (CSRS) resulted in risk-adjusted mortal-
ty of cardiac surgery dropping from 4.17% to 2.45% in the
rst three years of its existence (12) with less dramatic
mprovements since then (13) but was also associated with
ome unintended consequences including provider “gaming”
nd exacerbation of existing disparities in care (14). The
ennsylvania CABG public reporting program has had a
imilar experience (15). The Massachusetts cardiac surgery
eporting program utilized the STS database but also
ompared performance measures based on these clinical
ata sources with those from administrative billing sources
16). It was concluded that, “Cardiac surgery report cards
sing administrative data are problematic compared with
hose derived from audited and validated clinical data,
rimarily because of case misclassification and nonstandard-
zed end points.”
Public reporting of transplant program data provided to
he United Network for Organ Sharing (UNOS) has been
uccessful using risk-adjusted data confirmed by each pro-
ram audited periodically (17). As a result of this program,
he differences in outcomes among programs has become
airly small as each program does its best to improve its results.
CMS re-entered public reporting of hospital quality data
n 2005 when it released hospital-level process performance
ata on acute myocardial infarction (AMI), heart failure
HF), pneumonia, and surgical infection (18). This assess-
ent broadened last year when CMS added hospital-level
MI and HF mortality data to the reported metrics (19).
While physician-specific data have been used in provider
ncentive programs, public reporting of such data has been
imited. The CMS has attempted to collect physician-
pecific quality data through its Physician Voluntary Re-
orting Program in 2006 and the Physician Quality Report-
ng Initiative (PQRI) beginning in 2007 (20). Participation
n these programs has been limited, and no performance
ata are expected to be publicly reported from either
rogram. Other systems have been developed for using
ctual clinical data in feedback to physicians for the purpose
f quality improvement. Approaches such as these have
erformed well when compared to public reporting and
ay-for-performance programs (21,22).
In summary, large-scale public reporting efforts have
rimarily involved acute events—such as AMI, decompen-
ated HF, or procedures, such as cardiac surgery. They have
sually not entailed physician-specific performance mea-urement but rather have been summated at the hospital
evel, where statistical stability is greater due to a larger
umber of cases in the denominators. Finally, the more
uccessful programs have relied on clinical data sources to
void issues of case misclassification and to allow for risk
djustment of outcomes. Extrapolation of these experiences
o the ambulatory setting, where care is provided to patients
ith multiple comorbidities, occurs over time-spans mea-
ured in years, and involves multiple providers, has little or
o empiric evidence to support it. With this level of
ncertainty, concern has been expressed that programs of
hysician-level public reporting on ambulatory care pro-
esses may lead to unintended consequences that could
ffset their benefits (23,24).
xisting Reporting Principles
ther entities that have published public reporting guide-
ines, recommendations, or principles include the American
edical Association (AMA) (25), Massachusetts Medical
ociety (26), RAND (27), and the AQA Alliance (28). In
arch 2007, the National Committee for Quality Assur-
nce (NCQA) sought public comment on a Healthcare
ffectiveness Data and Information Set (HEDIS) Physician
easurement volume developed in an attempt to create a
tandardized national approach to physician measurement
nd reporting. In the fall of 2007, the New York Attorney
eneral entered into agreements with United Healthcare
nd other national managed care organizations whereby the
ealth plans agreed to abide by certain principles in devel-
ping and reporting their physician rating systems (29).
ommon themes among these various recommendations
or public reporting include a primary focus on quality
mprovement, physician involvement in public reporting
rograms, risk adjustment of measures, and monitoring for
nintended consequences.
CC Principles
hysician performance data, particularly in the area of
mbulatory care, are new and lack a solid evidence base
upporting their utility. Thus, it would seem prudent to
onduct pilot studies before widespread adoption on this
pproach. RAND, AQA Alliance, NCQA, and the Mas-
achusetts Medical Society have proposed such programs.
hose who proceed with physician-level public reporting on
erformance at this point should base their programs on the
ollowing principles:
1. The driving force behind physician performance
measurement and reporting systems should be to
promote quality improvement. Ideally, any assess-
ment program should promote improvement in the
quality and outcomes of care and have limited unin-
tended consequences. Some believe that the ultimate
goal of public reporting of physician performance is,
1996 Drozda et al. JACC Vol. 51, No. 20, 2008
Health Policy Statement on Public Reporting May 20, 2008:1993–2001instead, to place information into the hands of the
consumer. This belief comes from a philosophy which
says, “Let patients know what physician performance
is and they will vote with their feet.” This approach is
based on two assumptions, both of which have a weak
evidence base. The first is that the currently available
performance measurement methodology gives an ac-
curate picture of the quality of care rendered by the
individual cardiovascular specialist. The science of
physician performance measurement, in fact, is only
beginning to issue guidance about case mix adjust-
ment and adequate sample size (3). The second
assumption—that there is a surplus of cardiovascular
specialists from which the consumer can choose—is
also a problem since data show that we are actually
facing a shortage of such specialists as our population
ages (30,31). A well-designed public reporting pro-
gram should, therefore, be aimed at raising the per-
formance of all providers, thereby increasing access to
high-quality cardiovascular care for everyone.
2. Public reporting programs should be based on
performance measures with scientific validity. The
evidence supporting the clinical processes that are the
focus of the measures being used should be explicitly
stated. In addition, the program should be transparent
with respect to data sources, the validation of the data
collection, and the statistical and reporting method-
ologies used including the limitations of those meth-
odologies. Public reporting programs should make
this information available to physicians and the public
along with the results of any testing of the measure-
ment system. Other key elements of public reporting
for which the evidence base should be clear include
the methodologies used for risk/case-mix adjustment
and for attribution of specific measures to specific
providers. Recent publications describe important
methodologies to be used in these areas as well as in
the design of composite measures (3,32). These are
critical elements to ensure the credibility of public
reporting. In general, clinical as opposed to administra-
tive data sources are favored for provider performance
reporting to maximize accuracy and completeness (16).
Physicians, through their specialty societies, are
well-qualified to understand the clinically relevant
issues facing the field as well as how these can be
translated into credible performance measures. Public
reporting entities should, therefore, select cardiovas-
cular disease performance measures from the robust
sets already developed by the ACCF and the Amer-
ican Heart Association (AHA) with the AMA’s
Physician Consortium for Performance Improvement
(PCPI). It is similarly strongly recommended that
whenever possible measures used in public reporting
be endorsed by entities such as the National Quality
Forum (NQF) since metrics endorsed by this sort ofmulti-stakeholder organization have generally gone
through a rigorous development and approval process.
3. Public reporting programs should be developed in
partnership with physicians. Clinicians are respon-
sible for the burden of data collection and should be
ultimately the drivers of provider quality improve-
ment. Therefore, physicians should participate in
testing the measurement system prior to any public
reporting and should be offered feedback in a manner
that would help inform and stimulate practice change.
Additionally, for private health plans, provider con-
tracts should contain the physician’s consent to public
reporting of physician quality data before any such
program is undertaken. Health plans should afford
physicians the opportunity to review their data before
public release and the ability to formally appeal
information they believe to be incorrect.
4. Every effort should be made to use standardized
data elements to assess and report performance and
to make the submission process uniform across all
public reporting programs. A universal reporting
format will lower the administrative burden of data
entry; facilitate comparative analysis; maximize pro-
vider participation; and, therefore, create the most
meaningful platform for performance assessment and
improvement. This will require public and private
reporting entities to work together to develop the
necessary standards. Such standards for some clinical
data already exist in the STS database and in the
ACCF’s National Cardiovascular Data Registry
(NCDR™). The ACCF in partnership with the
AHA is also developing key data elements and defi-
nitions that should be utilized to harmonize data
collection for cardiovascular conditions (33–35). In
addition, the ACCF and AHA are working with the
NQF, CMS, The Joint Commission, NCQA, and
the PCPI to harmonize performance measures.
5. Performance reporting should occur at the appro-
priate level of accountability. Recognizing the com-
plexity in the delivery of health care, the Institute of
Medicine called for “shared accountability” as one of
its principles for a national system of performance
measurement and reporting, stating that improvement
“can be achieved only through the collaborative efforts
of multiple providers and multiple care settings” (36).
Indeed, the modern practice of cardiovascular medi-
cine is accomplished by teams of providers that
include nurses, nurse practitioners, physician assis-
tants, primary care physicians, and physicians in the
various subspecialties of cardiology. While individual
provider data have value to the team in its effort to
improve quality, these data are unlikely to be useful to
payers and patients. In addition, it is highly unlikely
that an individual provider sees a sufficient number of
patients to establish statistical validity. Thus, mea-
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May 20, 2008:1993–2001 Health Policy Statement on Public Reportingsurement and reporting should take into consideration
that the unit of accountability is the provider team
that has assumed the care of the condition or patient
population in question. These accountable units can
range from a solo practitioner, through a small group
practice, to a large multi-specialty practice. Reporting
at the accountable entity level recognizes the realities
of modern-day practice, directly addresses the prob-
lematic issue of attribution, and promotes health care
teamwork. Attributing an outcome or measure to a
single physician oversimplifies performance measure-
ment at best. At its worst, such an approach under-
mines the preferred model of team-based care and the
ideal collaborative design necessary to deliver patient-
centered, effective, and safe health care.
6. All public reporting programs should include a
formal process for evaluating the impact of the
program on the quality and cost of health care
including an assessment of unintended conse-
quences (37). Physician performance measurement,
particularly in the ambulatory setting, is still in its
early stage and there is limited experience with public
reporting of these measures. The potential impact of
unintended consequences on the quality and cost of
care is great, especially with respect to patient access
to care and physicians’ practice patterns. Those who
choose to publicly report data should be accountable
for analyzing their program’s consequences—both
good and bad; reporting the results of those analyses
to all of the involved constituencies; and modifying
the program in order to achieve maximum benefit for
patients. These rigorous analyses will not only serve to
make reporting programs more effective but should
also provide a stimulus for focused health-services
research and offer the potential for providing an
invaluable laboratory for quality improvement.
CCF Activity and Future Directions
he ACCF as a professional society, together with its state
hapters and individual members, has a tradition of quality
easurement and improvement. The College’s approach—a
ombination of information and quality improvement
ools—has proven effective in improving cardiovascular care
ithout employing public reporting.
In 2003, the ACCF revised its guiding mission to state
hat it would advocate for optimal patient care through the
evelopment and application of clinical practice guidelines.
tated another way, the College is dedicated to assisting
linicians in delivering high-quality, safe, effective, and
fficient care. Achieving these goals has required nothing
hort of a transformation and marked expansion of the
ollege’s programs and processes. These include working in
artnership with the AHA to produce cardiac data stan-
ards for use in electronic medical records and performance peasures, evidence-based clinical practice guidelines (38,
9), and performance measures developed using a rigorous
ethodology (2). In addition, the ACCF has developed
ppropriateness criteria (40) to promote the optimal use of
echnology and, through its NCDR™, is building the
nfrastructure needed to systematically measure and feed
ack cardiovascular care patterns to participating hospitals
nd physicians. The ACCF also has carried out highly
uccessful quality improvement projects that have broken
ew ground on how to achieve collaborative quality improve-
ent through programs, such as its Guidelines Applied in
ractice (GAP), Door to Balloon (D2B: An Alliance for
uality), and its newest Take ACTION campaign.
In working to achieve the goal of improved delivery of
uality cardiovascular care, the ACCF is concerned about
he opportunity costs presented by public reporting pro-
rams. The ACCF believes that our nation’s energies and
imited resources would be best spent developing the sys-
ems of care that are designed to achieve the high-quality
nd efficient care desired by all. These systems include
rganized approaches to care, such as the chronic care
odel and provider-based, patient-focused disease manage-
ent programs. Efforts are also underway to develop infor-
ation on the effectiveness of various clinical interventions
nd communicating that information to providers and
atients in a meaningful way. Many stakeholders, including
he ACCF, are addressing the challenge of developing and
aining the widespread adoption of robust, interoperable
ealth information technology to support these more so-
histicated and effective approaches to patient care. We face
he daunting challenge of finding the capital to invest in
hese new systems while designing new compensation mod-
ls to support them. The critical question that remains is
hether, given finite resources, physician-level reporting
ill help improve the quality of care or whether such
eporting may actually serve as an impediment to other
fforts aimed at achieving provider- and practice-level qual-
ty improvement.
onclusions
t its best, public reporting on the performance of cardio-
ascular specialists is intended to stimulate focused efforts to
liminate the gaps in care—from omission, commission,
nd inappropriateness—that jeopardize the health of pa-
ients and contribute to excessive expenditures. Poorly
esigned programs risk misleading patients about the qual-
ty of their care, damaging the therapeutic relationships with
heir providers, and creating greater disparities in care
elivery. To avoid these unintended consequences and to
chieve transparency that contributes to sound decision-
aking, the ACCF recommends public reporting programs
hat are based on scientifically valid performance measures
sing clinical rather than administrative data whenever
ossible. The programs should be designed in partnership
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Health Policy Statement on Public Reporting May 20, 2008:1993–2001ith those being measured and should report performance
t the level of the accountable entity in order to reflect the
ealities of current cardiovascular practice and to stimulate
xcellence in team-based care. Finally, the ACCF supports
rograms that fully disclose their methodology and that
ystematically evaluate for adverse as well as beneficial
esults. The principles outlined in this document point the
ay forward for physician performance reporting programs
n a way that will fulfill the legitimate need for transparency
hile promoting both the wise use of resources and the
elivery of high-quality health care.
taff
merican College of Cardiology Foundation
ohn C. Lewin, MD, Chief Executive Officer
harlene May, Senior Director, Clinical Policy and Guidelines
rin A. Barrett, Senior Specialist, Clinical Policy and
uidelines
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